Evidence map›Paper›PMID 33870493›Full record

ArticleEuropean journal of clinical investigation2021

SARS-CoV-2 antibodies: Comparison of three high-throughput immunoassays versus the neutralization test.

Riccardo Laterza, Annalisa Schirinzi, Rossella Bruno, Rosa Genco, Renato Contino, Angelo Ostuni, Francesca Di Serio

Open access · greenAbstract readComparative StudyLetter
In one paragraph

Article in European journal of clinical investigation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Riccardo LaterzaClinic Pathology Unit, University Hospital of Bari, Bari, Italy.ORCID https://orcid.org/0000-0001-5503-1478
Annalisa SchirinziClinic Pathology Unit, University Hospital of Bari, Bari, Italy.
Rossella BrunoImmunohaematology and Transfusion Medicine Service, University Hospital of Bari, Bari, Italy.
Rosa GencoClinic Pathology Unit, University Hospital of Bari, Bari, Italy.
Renato ContinoClinic Pathology Unit, University Hospital of Bari, Bari, Italy.
Angelo OstuniImmunohaematology and Transfusion Medicine Service, University Hospital of Bari, Bari, Italy.ORCID https://orcid.org/0000-0001-8391-7938
Francesca Di SerioClinic Pathology Unit, University Hospital of Bari, Bari, Italy.
University of Bari Aldo Moro · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antibodies, NeutralizingAntibodies, ViralBlood DonorsCoronavirus Nucleocapsid ProteinsCOVID-19COVID-19 Serological TestingCOVID-19 SerotherapyHigh-Throughput Screening AssaysHumansImmunization, PassiveImmunoassayImmunoglobulin GNeutralization TestsPhosphoproteinsSARS-CoV-2Spike Glycoprotein, CoronavirusAntibodies, NeutralizingAntibodies, ViralCoronavirus Nucleocapsid ProteinsImmunoglobulin Gnucleocapsid phosphoprotein, SARS-CoV-2PhosphoproteinsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2COVID-19immunoassayneutralizing antibodiesPRNTRBDSARS-CoV-2

Identifiers

PMID33870493
PMCPMC8250358
OpenAlexW3156594955

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.